Black Diamond Therapeutics, Inc.BDTXNASDAQ
Loading
Cash Generation ExpandingExpanding
Percentile Rank100
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$29.61M
↑ 172% vs avg
Percentile
P100
Near historical high
Streak
4 yr
Consecutive growthExpanding
Average
$-41.36M
Historical baseline
PeriodValueYoY Change
TTM$29.61M+147.5%
2024$-62.30M+6.6%
2023$-66.72M+21.6%
2022$-85.08M+15.0%
2021$-100.15M-92.1%
2020$-52.15M-111.3%
2019$-24.67M-191.9%
2018$-8.45M-259.6%
2017$-2.35M-